FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030142839> ?p ?o ?g. }

• W3030142839 endingPage "799" @default.
• W3030142839 startingPage "795" @default.
• W3030142839 abstract "Background Many eye diseases such as central retinal artery occlusion,glaucoma and ischemic optic neuropathy,etc.lead to retinal ischemia-reperfusion injury (RIRI) and furthmore visual functional damage.It is neeessary to study the treatment of RIRI.Objective This study was to observe and discuss the influence of aminoguanidine on the retina morphological changes and its mechanism after RIRI.Methods Eighty clean healthy male Japanese white rabbits were randomly divided into normal injury group,RIRI group and aminoguanidine (AG)treated group.The model of RIRI was established by infusing saline solution into the anterior chamber to elevate intraocular pressure (IOP) in both RIRI group and AG group.AG was intraperitoneally injected in the models of the AG group,and normal saline solution was used at the same method in tbe normal group and the RIRI group.The fundus photography and fundus fluorescein angiography(FFA) were pertormed on the rabbits at the moment of retina ischemia and 6,24 and 72 hours after reperfusion.The parts of rabbits were sacrificed 1,6,24 and 72 hours after reperfusion,followed by the enucleation of the eyeballs.Retinal section was prepared for TUNEL examination to evaluate the apoptosis of retinal cells.Nitric oxide (NO) concentration in retina was detected with nitrate reductase,and the activity of inducible nitric oxide synthase (iNOS) was measured by colorimetric detection.The use of the animals followed the Regulations for the Administration of Affairs Concerning Experimental Animals by State Science and Technology Commission.Results The fundus photography and FFA showed that the retinal edema was more mild,and the percentage of vascular occlusion was lower in the AG treatment group than that in RIRI group and the amount and area of fluorescein leakage were also smaller than the treatment group.The numbers of TUNEL positive cells in the AG treatment group were less than those in the RIRI model group at 1,6,24 and 72 hours after experiment (F分组 =2762.37,P =0.00 ; F时间 =894.24,P =0.00).Numbers of TUNEL positive cells between adjacent time points were significantly different in both RIRI model group and AG treatment group (RIRI group:q =24.475,36.591,-20.37,P＜0.05;AG group:q =20.94,16.79,-6.92,P＜0.05),with the peak value at 24 hours after experiment.NO contents were significantly higher in the RIRI model group compared to AG group at various time points(q =3.84,4.01,8.91,3.75,P＜0.05),and those between adjacent time points showed significant differences (RIRI group:q=4.77,13.403,-10.29,P＜0.05;AG group:q=4.55,9.05,-5.08,P＜0.05).iNOS activity was significantly elevated in the RIRI model group compared with AG group(q=-3.74,-4.94,-6.53,-3.98,P＜0.05),and obvious differences also were seen between the adjacent time points in both two groups(RIRI group:q =8.43,6.71,-6.39,P＜0.05 ;AG group:q =4.16,5.08,-3.93,P＜0.05).Conclusions Aminoguanidine can protect the retinal function and morpbology from oxidative stress damage after RIRI by reducing the NO level and inhibiting the iNOS activity in retina.Key words: Retina ischemia-reperfusion injury; Aminoguanidine; Apoptosis; Nitric oxide; Inducible nitric oxide synthase" @default.
• W3030142839 created "2020-06-05" @default.
• W3030142839 creator A5042444428 @default.
• W3030142839 date "2012-09-10" @default.
• W3030142839 modified "2023-09-22" @default.
• W3030142839 title "Influence of aminoguanidine on retina morphology and expression of nitric oxide and inducible nitric oxide synthase after retina ischemia-reperfusion injury" @default.
• W3030142839 doi "https://doi.org/10.3760/cma.j.issn.2095-0160.2012.09.007" @default.
• W3030142839 hasPublicationYear "2012" @default.
• W3030142839 type Work @default.
• W3030142839 sameAs 3030142839 @default.
• W3030142839 citedByCount "0" @default.
• W3030142839 crossrefType "journal-article" @default.
• W3030142839 hasAuthorship W3030142839A5042444428 @default.
• W3030142839 hasConcept C118487528 @default.
• W3030142839 hasConcept C126322002 @default.
• W3030142839 hasConcept C169760540 @default.
• W3030142839 hasConcept C190283241 @default.
• W3030142839 hasConcept C196795494 @default.
• W3030142839 hasConcept C2776391266 @default.
• W3030142839 hasConcept C2776449918 @default.
• W3030142839 hasConcept C2776474195 @default.
• W3030142839 hasConcept C2777093970 @default.
• W3030142839 hasConcept C2777397205 @default.
• W3030142839 hasConcept C2777622882 @default.
• W3030142839 hasConcept C2780114680 @default.
• W3030142839 hasConcept C2780248432 @default.
• W3030142839 hasConcept C2780827179 @default.
• W3030142839 hasConcept C519581460 @default.
• W3030142839 hasConcept C541997718 @default.
• W3030142839 hasConcept C55493867 @default.
• W3030142839 hasConcept C71924100 @default.
• W3030142839 hasConcept C86803240 @default.
• W3030142839 hasConceptScore W3030142839C118487528 @default.
• W3030142839 hasConceptScore W3030142839C126322002 @default.
• W3030142839 hasConceptScore W3030142839C169760540 @default.
• W3030142839 hasConceptScore W3030142839C190283241 @default.
• W3030142839 hasConceptScore W3030142839C196795494 @default.
• W3030142839 hasConceptScore W3030142839C2776391266 @default.
• W3030142839 hasConceptScore W3030142839C2776449918 @default.
• W3030142839 hasConceptScore W3030142839C2776474195 @default.
• W3030142839 hasConceptScore W3030142839C2777093970 @default.
• W3030142839 hasConceptScore W3030142839C2777397205 @default.
• W3030142839 hasConceptScore W3030142839C2777622882 @default.
• W3030142839 hasConceptScore W3030142839C2780114680 @default.
• W3030142839 hasConceptScore W3030142839C2780248432 @default.
• W3030142839 hasConceptScore W3030142839C2780827179 @default.
• W3030142839 hasConceptScore W3030142839C519581460 @default.
• W3030142839 hasConceptScore W3030142839C541997718 @default.
• W3030142839 hasConceptScore W3030142839C55493867 @default.
• W3030142839 hasConceptScore W3030142839C71924100 @default.
• W3030142839 hasConceptScore W3030142839C86803240 @default.
• W3030142839 hasIssue "09" @default.
• W3030142839 hasLocation W30301428391 @default.
• W3030142839 hasOpenAccess W3030142839 @default.
• W3030142839 hasPrimaryLocation W30301428391 @default.
• W3030142839 hasRelatedWork W1544478656 @default.
• W3030142839 hasRelatedWork W157521976 @default.
• W3030142839 hasRelatedWork W2177481758 @default.
• W3030142839 hasRelatedWork W2348280112 @default.
• W3030142839 hasRelatedWork W2348673841 @default.
• W3030142839 hasRelatedWork W2351599017 @default.
• W3030142839 hasRelatedWork W2362144155 @default.
• W3030142839 hasRelatedWork W2368606766 @default.
• W3030142839 hasRelatedWork W2373271853 @default.
• W3030142839 hasRelatedWork W2376781215 @default.
• W3030142839 hasRelatedWork W2378951915 @default.
• W3030142839 hasRelatedWork W2380095083 @default.
• W3030142839 hasRelatedWork W2385204917 @default.
• W3030142839 hasRelatedWork W2385232741 @default.
• W3030142839 hasRelatedWork W2387009885 @default.
• W3030142839 hasRelatedWork W2390202712 @default.
• W3030142839 hasRelatedWork W2393611469 @default.
• W3030142839 hasRelatedWork W2589216614 @default.
• W3030142839 hasRelatedWork W3031215756 @default.
• W3030142839 hasRelatedWork W3032641131 @default.
• W3030142839 hasVolume "30" @default.
• W3030142839 isParatext "false" @default.
• W3030142839 isRetracted "false" @default.
• W3030142839 magId "3030142839" @default.
• W3030142839 workType "article" @default.